211 related articles for article (PubMed ID: 28940440)
21. Intravenous diuretic day-care treatment for patients with heart failure.
Banerjee P; Tanner G; Williams L
Clin Med (Lond); 2012 Apr; 12(2):133-6. PubMed ID: 22586787
[TBL] [Abstract][Full Text] [Related]
22. Diuretics or ultrafiltration in the treatment of acute decompensated heart failure: An updated systematic review and meta-analysis.
Terpos V; Roumeliotis S; Georgianos PI; Papa E; Tsalikakis DG; Papachristou E; Liakopoulos V
Ther Apher Dial; 2024 Feb; 28(1):9-22. PubMed ID: 37469222
[TBL] [Abstract][Full Text] [Related]
23. Continuous infusion of frusemide in refractory oedema.
Lawson DH; Gray JM; Henry DA; Tillstone WJ
Br Med J; 1978 Aug; 2(6135):476. PubMed ID: 678930
[No Abstract] [Full Text] [Related]
24. Clinical Outcomes With Furosemide Versus Torsemide in Patients With Heart Failure: An Updated Systematic Review and Meta-Analysis.
Siddiqi AK; Javaid H; Ahmed M; Dhawadi S; Batool L; Zahid M; Muslim MO; Naeem K; Mahmood F; Hussain A
Curr Probl Cardiol; 2023 Nov; 48(11):101927. PubMed ID: 37453532
[TBL] [Abstract][Full Text] [Related]
25. Oral Furosemide and Hydrochlorothiazide/Amiloride versus Intravenous Furosemide for the Treatment of Resistant Nephrotic Syndrome.
Frățilă G; Sorohan BM; Achim C; Andronesi A; Obrișcă B; Lupușoru G; Zilișteanu D; Jurubiță R; Bobeică R; Bălănică S; Micu G; Mocanu V; Ismail G
J Clin Med; 2023 Nov; 12(21):. PubMed ID: 37959360
[TBL] [Abstract][Full Text] [Related]
26. Randomized double-blind clinical studies of ularitide and other vasoactive substances in acute decompensated heart failure: a systematic review and meta-analysis.
Mitrovic V; Forssmann WG; Schnitker J; Felix SB
ESC Heart Fail; 2018 Dec; 5(6):1023-1034. PubMed ID: 30246939
[TBL] [Abstract][Full Text] [Related]
27. Decongestion strategies in patients presenting with acutely decompensated heart failure: A worldwide survey among physicians.
Vazir A; Kapelios CJ; Agaoglu E; Metra M; Lopatin Y; Seferovic P; Mullens W; Filippatos G; Rosano G; Coats AJS; Chioncel O
Eur J Heart Fail; 2023 Sep; 25(9):1555-1570. PubMed ID: 37565377
[TBL] [Abstract][Full Text] [Related]
28. Comparison of diuretics and fluid expansion in the initial treatment of patients with normotensive acute pulmonary embolism: a systematic review and meta-analysis.
Febra C; Santos AR; Cabrita I; Bento J; Pacheco J; Mendes M; Isidro M; Batista R; Macedo AMAFM
Emerg Med J; 2024 Feb; 41(3):187-192. PubMed ID: 38253364
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of early ultrafiltration in patients with acute decompensated heart failure: a meta-analysis.
Chen S; Wang H; Ning B
Front Cardiovasc Med; 2023; 10():1234092. PubMed ID: 37920175
[TBL] [Abstract][Full Text] [Related]
30. Mortality of continuous infusion versus intermittent bolus of meropenem: a systematic review and meta-analysis of randomized controlled trials.
Ai MY; Chang WL; Liu CY
Front Microbiol; 2024; 15():1337570. PubMed ID: 38525074
[TBL] [Abstract][Full Text] [Related]
31. A novel, small-volume subcutaneous furosemide formulation delivered by an abdominal patch infusor device in patients with heart failure: results of two phase I studies.
Osmanska J; Brooksbank K; Docherty KF; Robertson S; Wetherall K; McConnachie A; Hu J; Gardner RS; Clark AL; Squire IB; Kalra PR; Jhund PS; Muntendam P; McMurray JJV; Petrie MC; Campbell RT
Eur Heart J Cardiovasc Pharmacother; 2024 Jan; 10(1):35-44. PubMed ID: 37804170
[TBL] [Abstract][Full Text] [Related]
32. Extended infusion of β-lactams significantly reduces mortality and enhances microbiological eradication in paediatric patients: a systematic review and meta-analysis.
Budai KA; Tímár ÁE; Obeidat M; Máté V; Nagy R; Harnos A; Kiss-Dala S; Hegyi P; Garami M; Hankó B; Lódi C
EClinicalMedicine; 2023 Nov; 65():102293. PubMed ID: 38021371
[TBL] [Abstract][Full Text] [Related]
33. Comparison Between Pantoprazole Intermittent Dosing and Continuous Infusion in Suspected Upper Gastrointestinal Bleeding Prior to Endoscopy: Impact of a Pharmacist-Driven Protocol to Reduce Utilization of Pantoprazole Continuous Infusion.
Hernandez IA; Morell J; Mulcahy L; Luzardo D
Cureus; 2023 Oct; 15(10):e48056. PubMed ID: 38046478
[TBL] [Abstract][Full Text] [Related]
34. Door-to-Diuretic Time and Short-Term Outcomes in Acute Heart Failure. A Systematic Review and Meta-Analysis.
Tariq MA; Malik MK; Khalid Z; Asrar A
Crit Pathw Cardiol; 2024 Apr; ():. PubMed ID: 38598546
[TBL] [Abstract][Full Text] [Related]
35. Door-to-diuretic time and mortality in patients with acute heart failure: A systematic review and meta-analysis.
Sampaio Rodrigues T; Garcia Quarto LJ; Nogueira SC; Theuerle JD; Farouque O; Burrell LM; Koshy AN
Am Heart J; 2024 Mar; 269():205-209. PubMed ID: 38359992
[TBL] [Abstract][Full Text] [Related]
36. A retrospective evaluation of the efficacy of intravenous bumetanide and comparison of potency with furosemide.
Nappi JM
Pharm Pract (Granada); 2013 Jan; 11(1):44-50. PubMed ID: 24155849
[TBL] [Abstract][Full Text] [Related]
37. Furosemide in pediatric intensive care: a retrospective cohort analysis.
Gaetani M; Parshuram CS; Redelmeier DA
Front Pediatr; 2023; 11():1306498. PubMed ID: 38293664
[TBL] [Abstract][Full Text] [Related]
38. A novel opportunity to improve heart failure care: focusing on subcutaneous furosemide.
Khan WJ; Arriola-Montenegro J; Mutschler MS; Bensimhon D; Halmosi R; Toth K; Alexy T
Heart Fail Rev; 2023 Nov; 28(6):1315-1323. PubMed ID: 37439967
[TBL] [Abstract][Full Text] [Related]
39. Pharmacodynamics of intravenous frusemide bolus in critically ill patients.
Cioccari L; Bellomo R
Crit Care Resusc; 2017 Dec; 19(4):355. PubMed ID: 29297629
[No Abstract] [Full Text] [Related]
40. Pharmacodynamics of intravenous frusemide bolus in critically ill patients.
Shann F
Crit Care Resusc; 2017 Dec; 19(4):355. PubMed ID: 29202262
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
